article thumbnail

EPA finalizing airplane emissions rules to bring US in line with international standards

JURIST

The US Environmental Protection Agency (EPA) on Monday announced that the agency is in the process of adopting its final greenhouse gas (GHG) emissions standards that will apply to certain new commercial airplanes manufactured in the US, including all new large passenger planes and commercial jets.

article thumbnail

A Short-Term Gain for a Long-Term Loss? The Build Back Better Act’s Medicare Drug Price Negotiation Program Ignores Hatch-Waxman/BPCIA Realities. and that May Mean Big Bad Business for Generic Drug/Biosimilar Manufacturers

FDA Law Blog

1) publish a list of selected drugs in accordance with section 1192; (2) enter into agreements with manufacturers of selected drugs with respect to such period, in accordance with section 1193; (3) negotiate and, if applicable, renegotiate maximum fair prices for such selected drugs, in accordance with section 1194; and. (4)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Rolls up its Sleeves on Price Negotiations, Sets Agenda for 2026 Negotiated Prices

FDA Law Blog

The topics focus on issues relevant in the first three years of the Negotiation Program—2026 to 2028. They are: Terms and conditions of the manufacturer agreement, including each party’s responsibilities. Approach for considering (1) the manufacturer-reported data elements and (2) evidence about alternative treatments.

article thumbnail

FDA Issues New Rules on Use of the Term “Healthy” on Food Labeling

Customs & International Trade Law

What Food Manufacturers Should Do The rule is effective February 25, 2025, and the compliance date of the rule is February 25, 2028. In preparation for the compliance date, food manufacturers should review their products to ensure that any product that uses a healthy label meets the new criteria.

article thumbnail

Proposed LDT Rule Raises Many Questions but Provides Few Answers

FDA Law Blog

The crux of the proposed rule lies in the addition of ten words: “ including when the manufacturer of these products is a laboratory.” These words would be added to the definition of “ in vitro diagnostic [IVD] products” in 21 C.F.R. Change to the IVD definition First, the mechanics of the change.

article thumbnail

Brands Are Reaping Rewards, Facing Risks Due to the Rise of the Nearly $500 Billion Social Commerce Market

The Fashion Law

percent from 2021 to 2028. As China continues to be a leading manufacturer and supplier to overseas markets, including but not limited to Southeast Asia, with its B2C and B2B platforms acting as crucial elements in the distribution chain, an enforcement strategy that does not specifically consider China would be woefully deficient.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). CMS will send the final manufacturer invoice for discount liabilities accrued by then on April 30, 2028.